title: Hyperlipidemia in a myeloma patient after bortezomib treatment.
authors.forename: Alessandro
authors.initials: A
authors.lastname: Gozzetti
authors.forename: Alberto
authors.initials: A
authors.lastname: Fabbri
authors.forename: Marzia
authors.initials: M
authors.lastname: Defina
authors.forename: Ida
authors.initials: I
authors.lastname: Chitarrelli
authors.forename: Monica
authors.initials: M
authors.lastname: Bocchia
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001897:Boronic Acids / Q000009:adverse effects* / Q000627:therapeutic use; D000069286:Bortezomib; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced*; D009101:Multiple Myeloma / Q000188:drug therapy*; D011719:Pyrazines / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib